It has come to our knowledge that certain unidentified persons are impersonating as employees of Kotak Alternate Asset Managers Limited (“KAAML”) through WhatsApp Groups and other social media platforms and are fraudulently inducing general public to invest monies with promises of high returns.
The fraudsters also induce the members of the WhatsApp group to trade through bogus applications, links of which are shared over WhatsApp or Telegram for public to download and make investments.
We want to caution everyone that neither KAAML nor any of its partners, directors, or employees have established any investment platforms/groups on WhatsApp or Telegram. We do not accept responsibility for any messages posted on such platforms or groups, and engaging in any such interactions or transactions will be solely at your own risk.
We strongly urge the public to exercise vigilance and conduct thorough due diligence before participating in or entrusting their funds to any social media platforms or groups claiming to be managed by employees of KAAML or affiliation with our Company.
In case you come across any such fake social media groups and fraudulent activity, you are requested to kindly contact at [email protected] so that appropriate action may be taken to curb such malafide activities.
In the evolving landscape of India's economy, we are the pioneers of change and innovation. Established as the nation's leading Alternate Asset company, Kotak Alternate Asset Managers Limited (KAAML) boasts a distinguished 20-year legacy.
In 2005, to bring about a sharper focus to this business, Kotak Alternate Asset Managers Limited was set up as the Group’s Alternate Asset practice with its first structured third party private equity and real estate funds.
At Kotak Bespoke Investment Advisory, we excel in designing investment strategies closely attuned to the financial aspirations of our discerning clientele.
Gain valuable insights into current market trends, investment opportunities, and challenges with our expert perspectives.
Kotak Private Equity specialises in harnessing the Indian entrepreneurial spirit to drive long-term, sustainable growth.
As a seasoned player in India's private equity landscape since 2005, Kotak Private Equity specialises in harnessing the Indian entrepreneurial spirit to drive long-term, sustainable growth. Expertly aligning with macroeconomic trends layered with deep insights and adaptive strategies, we drive India’s growth story.
Our true asset in Kotak Private Equity is foresight. It empowers us to identify emerging trends poised to redefine the future economy. With a keen understanding of complex sectors, we strategically invest in diverse ventures that range from companies with strong scaling potential to growth-stage entities with a defensible market position. This nuanced comprehension of Indian businesses equips us to generate alpha for investors.
Kotak’s two decades of investing experience embodies a comprehensive synergy of multi-sector expertise and investment acumen. Leveraging the same helps us deliver consistent returns for our investors while supporting India's vibrant growth trajectory with strategic foresight, especially within the consumer, financial services, technology and healthcare sectors.
Our inception was marked by early recognition of the healthcare sector's potential, spurred by demographic shifts, rising affluence, governmental support, and technological breakthroughs. As an early backer of several healthcare companies (hospitals, generic drug manufacturers) which are household names today, the Kotak VC team has become the port-of-call for founders of early-stage healthcare and life sciences companies
Today, our early investment strategy focuses on supporting future industry leaders at the forefront of innovation across products and services in healthcare and life sciences. These ventures are not just addressing unmet global health needs but are also carving new paths in medical sciences.
Our mission is to kindle the flames of innovation across the board, whether through med-tech advancements, AI commercialization, or pivotal R&D and industrial capacity investments. Our investment scope spans from Seed to Series B stages across life sciences, aiming to cultivate the industry's future vanguards.
As we progress from the potential early promise to mature growth, Kotak Private Equity's late-stage investment strategy is defined by a symbiotic partnership with promising leaders poised for industry dominance.
Beyond healthcare, our strategy is to maintain a healthy balance between investing in traditional industries seeking growth capital and emerging sunrise sectors at the cusp of transformation, such as Media and Entertainment, Retail, Manufacturing, New-age Technology and IT & ITES businesses.
Our USP is our wide network of associations, which includes proprietary multi-sector connects (built over two decades), Kotak group synergies, and a deep network of third-party providers. This comprehensive scope of our network allows us to originate and engage with deep diligence on every significant deal happening in the country.
With unique access to cross-pollinated intellectual knowledge from our ecosystem and peers, we possess unparalleled insights, enabling us to generate consistent returns for our investors. Our expertise and collaborative approach make us trusted partners in our investors' financial success as we continue to scout and support moonshot innovations and leaders of tomorrow.
A two-decade legacy of market innovation and growth.
Collaborative connections via Kotak's expansive network.
Real-time, on-the-ground intelligence.
Premier network access, opening prime opportunities.
Strong links to third-party investors for enhanced opportunities.
Identifying and investing in future success stories.
Diligence from vast experience and multiple touchpoints in the industry ecosystem.
Expertise in sector dynamics for informed decision-making.
Exit planning for optimal profitability.
Building India's tomorrow's visionaries while generating financial gains
We've secured funding from our investors through multiple distinct funds to invest in businesses with high potential. Current strategies from where we are investing:
Healthcare and lfesciences
2018
Early
19
Sector agnostic
2021
13
Growth/Late stage
USD 250 million
Policy Bazaar